Considerations for the safe prescribing and use of COX‐2‐specific inhibitors
暂无分享，去创建一个
R. Day | J. Edmonds | P. Sambrook | P. Brooks | G. McColl | G. Macdonald | J. Horowitz | G. Littlejohn | S. Shakib | P. Fletcher | L. Cleland | N. Yeomans | Mark A. Brown | J. Bertouch | D. Barraclough | S. Kerr | L. E. Clemens | Steven J. Crowley | Julien P. DeJager | Gary R. Franks | David C. Harris | Michael Johnston | Murray W. Verso